A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
Clinical trial NCT06015295 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06015295
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-07
- Primary completion
- 2028-03-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.